Radiation therapy of malignant parotid tumours.
Explore the source record for details and available documents.
Adenocarcinoma↗
Biomedical subjects
P Tepmongkol
Publications and source records attributed to P Tepmongkol.
The use of ambiphilic dermatological cream and radiation dermatitis in radiation therapy: a clinical study at Siriraj hospital, Bangkok.
Explore the source record for details and available documents.
Adult↗
Radiation therapy in the management of bronchogenic carcinoma.
Explore the source record for details and available documents.
Adolescent↗
Complications after radiation therapy for carcinoma of cervix uteri.
Explore the source record for details and available documents.
Adult↗
Radiation therapy for carcinoma of cervix uteri a clinical study in Siriraj Hospital.
Explore the source record for details and available documents.
Adenocarcinoma↗
Radiation therapy in the treatment of malignant ovarian tumours. A clinical study at Siriraj Hospital.
Explore the source record for details and available documents.
Adenocarcinoma↗
Large intravenous dose of methotrexate and radiotherapy in the treatment of advanced oral cancers.
Explore the source record for details and available documents.
Cobalt Radioisotopes↗
Whole-lung irradiation in the treatment of pulmonary metastases.
Explore the source record for details and available documents.
Adenocarcinoma↗
Radiation therapy in the treatment of keloids.
Explore the source record for details and available documents.
Humans↗
Matastases from unknown primary tumours.
Explore the source record for details and available documents.
Adolescent↗
The combined therapy of carcinoma of the tongue by using bleomycin and radiation.
Explore the source record for details and available documents.
Adult↗
Serum tissue polypeptide specific antigen (TPS) in patients with cervical carcinoma: preliminary report.
Tissue polypeptide specific antigen (TPS) was measured by TPS ELISA in the sera of 88 patients with FIGO stage II and III cervical cancer and 93 healthy Thai women as the control group. The mean serum TPS levels were 63.1 U/L in the control group, and 166.4 and 363.2 U/L in stage II and III cervical cancer respectively. The mean of the control group and stage II patients were not significantly different while the mean of stage III patients was significantly different from those two groups (p < 0.0005). With the cut-off value of 90 U/L, the rates of TPS elevation were 22/35 (65.7%) in stage II and 42/53 (79.2%) in stage III patients. As for the pathology, squamous cell carcinoma showed a statistical difference from adenocarcinoma and adenosquamous carcinoma of P = 0.001. For squamous cell carcinoma, there was no difference between the keratinized and non-keratinized type (P = 0.451). TPS is not sensitive in stage II. However, it might be useful for predicting prognosis if the elevation is significantly high, and distant metastases or local recurrence should be investigated.
Adult↗